Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)

被引：0
|
作者：
Costantini, Adrien
Corny, Jennifer
Fallet, Vincent
Renet, Sophie
Friard, Sylvie
Chouaid, Christos
Duchemann, Boris
Giroux-Leprieur, Etienne
Taillade, Laurent
Doucet, Ludovic
Wislez, Marie
Tredaniel, Jean
Cadranel, Jacques
Jouveshomme, Stephane
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.OA1476
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1476
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    ERJ OPEN RESEARCH, 2018, 4 (02)
  • [2] Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab
    Freeman, A. T.
    Lesperance, M.
    Wai, E. S.
    Croteau, N. S.
    Fiorino, L.
    Geller, G.
    Brooks, E. G.
    Poonja, Z.
    Fenton, D.
    Irons, S.
    Ksienski, D.
    CURRENT ONCOLOGY, 2020, 27 (02) : 76 - 82
  • [3] Nivolumab after Progression to Platinum- Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Lopez Flores, M.
    Diz Tain, P.
    Delgado Sillero, I.
    Sanchez Cousido, L.
    Lopez Gonzalez, A.
    Pedraza Lorenzo, M.
    Rodriguez Sanchez, A.
    Castanon Lopez, C.
    Nieto Mangudo, B.
    Garcia Casabal, F.
    De Sande Gonzalez, L.
    Garcia Palomo, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1916 - S1917
  • [4] Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression
    Ricciuti, Biagio
    Genova, Carlo
    Bassanelli, Maria
    De Giglio, Andrea
    Brambilla, Marta
    Metro, Giulio
    Baglivo, Sara
    Dal Bello, Maria Giovanna
    Ceribelli, Anna
    Grossi, Francesco
    Chiari, Rita
    CLINICAL LUNG CANCER, 2019, 20 (03) : 178 - +
  • [5] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [6] Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
    Rogado, J.
    Fenor De La Maza, M. D.
    Pacheco-Barcia, V.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Ballesteros, A.
    Mondejar, R.
    Donnay, O.
    Obispo, B.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2107 - S2108
  • [7] Predictive and Prognostic Clinical and Pathological Factors of Nivolumab Efficacy in Non-Small-Cell Lung Cancer (NSCLC) Patients
    Martin, Paloma
    De Julian, Maria
    Perez Altozano, Javier
    Salvador Coloma, Carmen
    Garcia Sanchez, Jose
    Insa Molla, Amelia
    Martin, Maria
    Mielgo Rubio, Xabier
    Marin, Sara
    Blasco Cordellat, Ana
    Blasco Cordellat, Sara
    Girones, Regina
    Marquez, Diego
    Aparisi, Francisco
    Bas Cerda, Maica
    Juan, Oscar
    Garde-Noguera, Javier
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1328 - S1329
  • [8] Durability of Efficacy with Selpercatinib in Patients (pts) with RET Fusion plus Non-Small-Cell Lung Cancer (NSCLC)
    Drillon, Alexander E.
    Subbiah, Vivek
    Gautschi, Oliver
    Tomasini, Pascale
    De Braud, Filippo G.
    Solomon, Benjamin
    Tan, Daniel Shao-Weng
    Alonso, Guzman
    Wolf, Juergen
    Park, Keunchil
    Goto, Koichi
    Soldatenkova, Victoria
    Szymczak, Sylwia
    Barker, Scott S.
    Puri, Tarun
    Lin, Aimee K.
    Loong, Herbert
    Besse, Benjamin
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 150 - 150
  • [9] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [10] Aneuploidy carries poor prognosis in non-small-cell lung cancer (NSCLC) patients (pts)
    Wegrzynowicz, E
    Dziadziuszko, R
    Kardas, I
    Limon, J
    Kurowski, K
    Jassem, J
    LUNG CANCER, 2004, 45 : S34 - S34
12345